Table 1

Relationship of RhoGDI2 immunohistochemical expression with pathological and clinical variables: Association of RhoGDI2 immunohistochemical expression with tumor grade, stage, and histological type

VariableCategoryAll n = 51GDI2 = 0an = 14 (27%)GDI2 = 1bn = 37 (73%)Pc
Grade1–2142 (14%)12 (86%)0.08
3–4204 (20%)16 (80%)
Nonurothelial1710 (59%)7 (41%)
StagedTa102 (20%)8 (80%)0.08
T1–T4244 (17%)20 (81%)
Nonurotheliale1710 (59%)7 (41%)
HistologyUrothelial346 (18%)28 (82%)0.03
Nonurothelial1710 (59%)7 (41%)
  • a GDI2 = 0, absent or reduced staining for RhoGDI2.

  • b GDI2 = 1, staining for RhoGDI2 similar to normal urothelium.

  • c Ps are based on the Pearson χ2 test.

  • d Union International Contre Cancer (UICC)/2002 (14) .

  • e All were stage ≥ T2.